SCHEMBL29891577

SCHEMBL29891577

Cn1c(=O)c(C#N)c(O)c2ccc(Br)cc21

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGLN1 Q9GZT9 2/20 0.53
GAA P10253 4/20 0.38
KMT2A Q03164 3/20 0.38
MEN1 O00255 2/20 0.38
PTGES O14684 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
TYRO3 Q06418 2/20 0.37
PDGFRA P16234 1/20 0.37
CDK5 Q00535 1/20 0.37
CCNB2 O95067 1/20 0.36
CDK1 P06493 1/20 0.36
CCNB1 P14635 1/20 0.36
CCNB3 Q8WWL7 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
GSK3B P49841 3/20 0.35
ALDH1A1 P00352 4/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
LMNA P02545 1/20 0.35
CYP1A2 P05177 1/20 0.35
KDM4E B2RXH2 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23410062 1.00 EGLN1 (0.53) EGLN1GAAKMT2AMEN1PTGES
SCHEMBL23410095 0.89 GSK3B (0.45) EGLN1GAAKMT2AMEN1NPSR1
SCHEMBL29891687 0.84 LMNA (0.41) EGLN1KMT2AMEN1RXFP1SMN1; SMN2
SCHEMBL23410160 0.84 LMNA (0.41) EGLN1KMT2AMEN1RXFP1SMN1; SMN2
SCHEMBL29891499 0.83 ATM (0.46) EGLN1GAAKMT2AMEN1ALDH1A1
SCHEMBL29891748 0.83 PTGES (0.42) EGLN1GAAKMT2AMEN1PTGES
SCHEMBL23410108 0.83 PTGES (0.42) EGLN1GAAKMT2AMEN1PTGES
SCHEMBL23410193 0.83 CYP2C19 (0.48) GAAKMT2AMEN1GSK3BALDH1A1
SCHEMBL23410287 0.83 ATM (0.46) EGLN1GAAKMT2AMEN1ALDH1A1
SCHEMBL29892115 0.83 CYP2C19 (0.48) GAAKMT2AMEN1GSK3BALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119564686-A DGK alpha inhibitors as immune activation substituted aminoquinolones of (2) 拜耳公司 2025-03-07 CN disclosed
CN-119523983-A DGK alpha inhibitors as immune activation substituted aminoquinolones of (2) 拜耳公司 2025-02-28 CN disclosed
CN-119424429-A DGK alpha inhibitors as immune activation substituted aminoquinolones of (2) 拜耳公司 2025-02-14 CN disclosed
WO-2025030002-A2 DGK TARGETING COMPOUNDS AND USES THEREOF ARVINAS OPERATIONS, INC. (US) 2025-02-06 WO disclosed
CN-115003665-B DGK alpha inhibitors as immune activation substituted aminoquinolones of (2) 拜耳公司 2024-11-08 CN disclosed
CN-115210238-B Substituted aminoquinolones as dgkα inhibitors for immune activation 拜耳公司 2024-08-27 CN disclosed
CN-115003665-A Substituted aminoquinolones as immunoactive DGK alpha inhibitors 拜耳公司 2022-09-02 CN disclosed